Can the Relationship between Doctors and Drug Companies Ever Be a Healthy One?
article has not abstract
Vyšlo v časopise:
Can the Relationship between Doctors and Drug Companies Ever Be a Healthy One?. PLoS Med 6(7): e32767. doi:10.1371/journal.pmed.1000075
Kategorie:
The PLoS Medicine Debate
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000075
Souhrn
article has not abstract
Zdroje
1. AngellM
2009 Relationships with the drug industry: Keep at arm's length. BMJ 338 b222
2. CampbellEG
GruenRL
MountfordJ
MillerLG
ClearyPD
2007 A national survey of physician-industry relationships. New Engl J Med 356 1742 1750
3. CareyB
HarrisG
2008 July 12 Psychiatric group faces scrutiny over drug industry ties. The New York Times. Available: http://www.nytimes.com/2008/07/12/washington/12psych.html?hp. Accessed 15 June 2009
4. Hopkins TanneJ
2009 Pfizer to disclose payments of $500 to healthcare prescribers. BMJ 338 b689 doi:10.1136/bmj.b689
5. WazanaA
2000 Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 283 373 380
6. HagerM
RussellS
FletcherSW
2008 Continuing education in the health professions: Improving healthcare through lifelong learning. Chairman's summary of the conference. The Josiah Macy, Jr. Foundation. Available: http://www.josiahmacyfoundation.org/documents/Macy_ContEd_1_7_08.pdf. Accessed 15 June 2009
7. MoghimiY
2006 The “PharmFree” campaign: Educating medical students about industry influence. PLoS Med 3 e30 doi:10.1371/journal.pmed.0030030
8. GodleeF
2009 Doctors, patients, and the drug industry. BMJ 338 b463
9. LexchinJ
BeroLA
DjulbegovicB
ClarkO
2003 Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 326 1167 1170
10. MoynihanR
2008 Key opinion leaders: Independent experts or drug representatives in disguise? BMJ 336 1402 1403
11. MoynihanR
2008 Doctors' education: The invisible influence of drug company sponsorship. BMJ 336 416 417
12. Association of Health Care Journalists 2004 Fundraising policy. Available: http://www.healthjournalism.org/center-fundraisingPolicy.php. Accessed 15 June 2009
13. The PLoS Medicine Editors 2004 Prescription for a healthy journal. PLoS Med 1 e22 doi:10.1371/journal.pmed.0010022
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases
- Ethics Without Borders